StatOrigin open statistical archive
Industries Indicators Regions Rankings Compare Sources

Pharmaceuticals in Germany

6 verified figures for Germany, covering 6 indicators from 1 primary source. Every figure links to the report it came from.

Cite & reuse Get this data as JSON
Verification 6 verified data points Updated 17 Sep 2026 Last verified 17 Sep 2026 Reviewed 17 Sep 2026 Next update Sources typically refresh annually

The short version

Key takeaways

  1. Label extensions for approved medicines in Germany stood at 20 in 2025 (VFA). VFA ↗ T2 National
  2. New medicines launched with orphan drug designation in Germany totalled 14 in 2025 (VFA). VFA ↗ T2 National
  3. New rare disease drug launches in Germany totalled 25 in 2025 (VFA). VFA ↗ T2 National
  4. Novel active substance launches in Germany stood at 37 in 2025 (VFA). VFA ↗ T2 National
  5. Chemically synthesized share of new medicine launches in Germany stood at 57% in 2025 (VFA). VFA ↗ T2 National
  6. Genetically engineered share of new medicine launches in Germany stood at 41% in 2025 (VFA). VFA ↗ T2 National

The complete table

Pharmaceuticals data for Germany

Every row links to its own page with the full source, verbatim quote and citation.

6 data points across 6 indicators. Each line shows the latest value; open a line for earlier periods and forecasts.

Download CSV
IndicatorPeriodValueSourceType
Chemically synthesized share of new medicine launches202557%VFAT22025actual→
Genetically engineered share of new medicine launches202541%VFAT22025actual→
Label extensions for approved medicines202520VFAT22025actual→
New medicines launched with orphan drug designation202514VFAT22025actual→
New rare disease drug launches202525VFAT22025actual→
Novel active substance launches202537VFAT22025actual→

Primary documents

Sources

1 primary source documents. Every figure on this page traces to one of these.
Document Publisher Authority tier Published Accessed Locator Data points
Neue Medikamente in Deutschland: Innovationsbilanz 2025 Press release VFA T2 National — 17 Sep 2026 Herstellungsarten; Innovationsbilanz 2025; Medikamente gegen seltene Erkrankungen 6

Report snapshots are retained internally for verification only and are never redistributed. Where a figure comes from a paywalled report, only the number published in its public summary is recorded.

All 6 collected records for Germany are published as verified.

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. Each figure's own page carries APA, MLA, Chicago and BibTeX citations naming its original publisher.

StatOrigin. (2026). Pharmaceuticals in Germany: statistics. Retrieved from https://statorigin.org/industries/pharmaceuticals/germany

Get this data as JSON